• Saioa Zalba Marcos, María Luisa Antelo, Arkaitz Galbete, Maialen Etayo, Eva Ongay, and José Antonio García-Erce.
• Servicio de Hematología y Hemoterapia, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
• Med Clin (Barc). 2020 Oct 23; 155 (8): 340343340-343.

BackgroundSARS-CoV-2 infection is clinically very heterogeneous, varying from asymptomatic to severe clinical conditions with a fatal outcome. Some studies suggests that the ABO blood group could be a biological marker of susceptibility for the development of the disease.Patients And MethodsWe collected data from patients admitted with COVID-19 infection who had ABO blood group recorded, and analyzed the incidence by groups, compared with the global population in Navarre, as well as their main complications and evolution.ResultsGroup O was proportionally less represented in the hospitalized patients with respect to the global population, although the difference was not statistically significant. Group B had significantly higher rates of thrombotic complications and required more admissions in intensive care units.ConclusionThe study suggests a lower susceptibility to infection in group O and a higher risk of complications in group B. Studies with a larger sample size are required in order to obtain significant results.Copyright © 2020 Elsevier España, S.L.U. All rights reserved.

37 keywords...

hide…